Skip to main content

Table 7 Levels of UA and UA/Cr ratio between severe and moderate symptoms and three time points by gender

From: Association of serum uric acid levels with COVID-19 severity

Fixed Effects UA UA/Cr ratio
Male Female Male Female
Effect Size 95% CI Effect Size 95% CI Effect Size 95% CI Effect Size 95% CI
Moderate Ref Ref Ref Ref Ref Ref Ref Ref
Severe −0.17 (− 0.29, − 0.05) 0.07 (−0.11, 0.24) − 0.19 (− 0.35, − 0.04) 0.02 (−0.15, 0.19)
Admission Ref Ref Ref Ref Ref Ref Ref Ref
Discharge −0.05 (−0.12, 0.01) −0.11 (− 0.18, − 0.04) −0.06 (− 0.14, 0.01) −0.18 (− 0.25, − 0.12)
Follow-up 0.04 (− 0.04, 0.13) 0.04 (− 0.03, 0.11) 0.05 (− 0.04, 0.14) −0.03 (− 0.10, 0.04)
  1. Note: Linear mixed effects models were used to assess changes of levels of UA and UA/Cr ratio between severe and moderate symptoms and three time points by gender
  2. Abbreviations: UA Uric acid, Cr Creatinine